Baird served as a lead co-manager on this transaction
AboutQuintiles Transnational Holdings Inc. (“Quintiles” or the “Company”) (NYSE: Q) recently completed a follow-on offering of 17,250,000 shares of common stock at a price of $52.00 per share, generating gross proceeds of $897 million. All of the shares offered were sold by selling shareholders of Quintiles. Quintiles will not receive any proceeds from the sale of shares in the offering.
Quintiles is the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 28,000 employees conducting business in approximately 100 countries. Quintiles applies the breadth and depth of its service offerings along with extensive therapeutic, scientific and analytics expertise to help the Company’s customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes. Quintiles is headquartered in Durham, North Carolina.
For additional information about this transaction, please contact:
- March 2014
- Quintiles Transnational Holdings Inc.
- Target Location
- North America